Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | April 12, 2012 | ||||
| Last Updated Date | February 7, 2013 | ||||
| Start Date ICMJE | April 2012 | ||||
| Primary Completion Date | October 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
SpO2 Accuracy Verification Study, SpO2 between 70% & 100% [ Time Frame: approximately 1 hour ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01583634 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin | ||||
| Official Title ICMJE | Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin | ||||
| Brief Summary | This pilot study is designed to calibrate and validate the Mespere VA Oximeter against a CO-Oximeter on healthy volunteers. |
||||
| Detailed Description | Mespere VA (Venous and Arterial) Oximeter is a novel non-invasive medical device for simultaneous monitoring of venous blood oxygenation through the right external jugular vein and arterial blood oxygenation through the finger tip (SpO2). The conventional pulse oximeter has been a standard in clinical care for non-invasive hemodynamic monitoring, which only measures the arterial blood oxygenation. There are many clinical situations where tissue hypoxia may exist despite normal values obtained by conventional pulse oximeter. This can be cause by inadequate monitoring of oxygen demand (i.e. venous oxygen saturation) of the tissues. The aim of monitoring tissue hypoxia can be achieved by monitoring the balance between oxygen supply (via arterial oxygen saturation) and oxygen demand (via venous oxygen saturation). The existing method for venous blood oxygenation monitored is either through an invasive fiber optic catheter, or intermittently by blood sampling and CO-oximetry. However, catheterization can be costly and can include inherent risks. Furthermore, there is the need for catheter recalibration against a CO-oximeter every 4- 6 hours. Therefore, due to the inherent risks of catheterization, venous oximetry is limited only to those critically ill patients. The clinical application of venous oximetry is numerous, including severe sepsis and septic shock, severe trauma and hemorrhagic shock, and heart failure and cardiac arrest. By non-invasively monitoring both venous and arterial blood oxygenation, Mespere VA Oximeter provides more complete information on patient hemodynamics and has clear advantages over conventional pulse oximeters. |
||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Retention: Samples With DNA Description: Whole blood |
||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Healthy volunteers between the ages of 21 and 49 years of either gender, and a range of skin tones |
||||
| Condition ICMJE | Healthy Volunteers | ||||
| Intervention ICMJE |
|
||||
| Study Group/Cohort (s) | Healthy volunteers
5 subjects (male and female)
Interventions:
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 9 | ||||
| Completion Date | October 2012 | ||||
| Primary Completion Date | October 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 21 Years to 49 Years | ||||
| Accepts Healthy Volunteers | Yes | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01583634 | ||||
| Other Study ID Numbers ICMJE | MLS STP-9000011, MESP01 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Mespere Lifesciences Inc. | ||||
| Study Sponsor ICMJE | Mespere Lifesciences Inc. | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Mespere Lifesciences Inc. | ||||
| Verification Date | February 2013 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||